Pyridostigmine Bromide Tablet
Product Images NDC 68382-659

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 68382-659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E701125e Efea 470b Ac59 D9db068436a6 01

Chemical structure of pyridostigmine bromide, depicting its molecular arrangement including a pyridine ring with a methyl and a positively charged nitrogen, an ester group, and a bromide ion.*

FDA Label Image

E701125e Efea 470b Ac59 D9db068436a6 02

Pyridostigmine Bromide Tablets, USP 60 mg oral tablets in unit-of-use packaging by Zydus Pharmaceuticals (USA) Inc. The label shows two round white tablets, one with imprint '659' and one with a scored cross. Package contains 30 tablets. It includes storage and handling instructions, emphasizing moisture sensitivity. The product is manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.